Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30014093
Basic Information
VIS ID
TVIS30014093
Fusion event
HIV-SMG1 integration
Validated
Yes
Detection method
invPCR
Data source
download(RID)
Sample type
PBMC
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2007
PubMed ID
17262715
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr16
Cytoband
p12.3
Reference genome
GRCh37/hg19
Start
18893143/18881821 (Hg38)
End
18893143/18881821 (Hg38)
Orient
+
Location type
Intronic
Target gene
SMG1
miRNAs that regulate target gene
hsa-mir-335-5p
;
hsa-mir-877-5p
;
hsa-mir-615-3p
;
hsa-mir-92b-3p
;
hsa-mir-361-5p
;
hsa-mir-181a-5p
;
hsa-mir-106a-5p
;
hsa-mir-100-5p
;
hsa-mir-17-3p
;
hsa-let-7b-5p
;
hsa-mir-19a-3p
;
hsa-mir-19b-3p
;
hsa-mir-3184-3p
;
hsa-mir-6890-3p
;
hsa-mir-4709-5p
;
hsa-mir-4740-5p
;
hsa-mir-4267
;
hsa-mir-891a-3p
;
hsa-mir-1256
;
hsa-mir-142-3p
;
hsa-mir-6515-5p
;
hsa-mir-6739-5p
;
hsa-mir-6733-5p
;
hsa-mir-3153
;
hsa-mir-1273a
;
hsa-mir-31-5p
;
hsa-mir-6797-5p
;
hsa-mir-1249-5p
;
hsa-mir-650
;
hsa-mir-3612
;
hsa-mir-5681a
;
hsa-mir-6847-5p
;
hsa-mir-4802-5p
;
hsa-mir-548aw
;
hsa-mir-6720-5p
;
hsa-mir-6512-3p
;
hsa-mir-4795-3p
;
hsa-mir-6499-3p
;
hsa-mir-1468-3p
;
hsa-mir-548x-5p
;
hsa-mir-548g-5p
;
hsa-mir-548f-5p
;
hsa-mir-548aj-5p
;
hsa-mir-4302
;
hsa-mir-126-5p
;
hsa-mir-183-5p
;
hsa-mir-4666a-3p
;
hsa-mir-648
;
hsa-mir-4519
;
hsa-mir-338-5p
;
hsa-mir-5583-3p
;
hsa-mir-559
;
hsa-mir-548y
;
hsa-mir-548w
;
hsa-mir-548o-5p
;
hsa-mir-548j-5p
;
hsa-mir-548i
;
hsa-mir-548h-5p
;
hsa-mir-548d-5p
;
hsa-mir-548c-5p
;
hsa-mir-548bb-5p
;
hsa-mir-548b-5p
;
hsa-mir-548ay-5p
;
hsa-mir-548au-5p
;
hsa-mir-548as-5p
;
hsa-mir-548ar-5p
;
hsa-mir-548aq-5p
;
hsa-mir-548ap-5p
;
hsa-mir-548am-5p
;
hsa-mir-548ak
;
hsa-mir-548ae-5p
;
hsa-mir-548ad-5p
;
hsa-mir-548ab
;
hsa-mir-548a-5p
;
hsa-mir-4422
;
hsa-mir-4282
;
hsa-mir-6835-3p
;
hsa-mir-548n
;
hsa-mir-539-5p
;
hsa-mir-545-5p
;
hsa-mir-330-3p
;
hsa-mir-362-3p
;
hsa-mir-329-3p
;
hsa-mir-4311
;
hsa-mir-4659b-3p
;
hsa-mir-4659a-3p
;
hsa-mir-6875-3p
;
hsa-mir-8070
;
hsa-mir-6842-3p
;
hsa-mir-647
;
hsa-mir-502-5p
;
hsa-mir-4687-3p
;
hsa-mir-7974
;
hsa-mir-4679
;
hsa-mir-3189-3p
;
hsa-mir-4762-5p
;
hsa-mir-141-5p
;
hsa-mir-212-5p
;
hsa-mir-510-3p
;
hsa-mir-488-3p
;
hsa-mir-3169
;
hsa-mir-4662b
;
hsa-mir-4647
;
hsa-mir-4426
;
hsa-mir-548ah-5p
;
hsa-mir-3609
;
hsa-mir-548t-5p
;
hsa-mir-548az-5p
;
hsa-mir-5698
;
hsa-mir-143-5p
;
hsa-mir-4430
;
hsa-mir-3652
;
hsa-mir-4284
;
hsa-mir-122-5p
;
hsa-mir-504-3p
;
hsa-mir-3135b
;
hsa-mir-2276-3p
;
hsa-mir-4638-5p
;
hsa-mir-1307-3p
;
hsa-mir-6741-3p
;
hsa-mir-1304-3p
;
hsa-mir-4485-5p
;
hsa-mir-5693
;
hsa-mir-6848-3p
;
hsa-mir-6843-3p
;
hsa-mir-1193
;
hsa-mir-6845-3p
;
hsa-mir-6812-3p
;
hsa-mir-2392
;
hsa-mir-575
;
hsa-mir-4676-5p
;
hsa-mir-6858-3p
;
hsa-mir-32-5p
;
hsa-mir-92a-3p
;
hsa-mir-3125
;
hsa-mir-3916
;
hsa-mir-5584-5p
;
hsa-mir-6859-5p
Nearest miRNA
hsa-mir-1225/Upstream/387245; hsa-mir-11401/Downstream/2624228;
Nearest TSS
ENST00000527434/Upstream/2160;
ENST00000565782/Downstream/15053;
Nearest CpG islands
None/Target,
chr16-CpG: 29/Upstream/79744
,
chr16-CpG: 119/Downstream/43887
Upstream sequence
TTGATATCAGGCTATCAAAGAATATAAAGGTATACAAGTTTTCATATGAGTTCCATCTTATGTTCAGAGAAGATTACTTTCTGAGGCTTTTCCTATAGTG
Downstream sequence
TGCTATTCGTAGTATGCTGAAAAACTAAAAGGAAACCCaataatttaaaagtaaaattataataaatattatttaaaaaCGAAAGAATAAGATTTAAAAA
Reference
Ikeda, T., et al. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy. J Infect Dis,2007, 195(5): 716-725.
Sample Information
×
Sample type
PBMC
Gender
Female
CpG Island Information
×
Download
Curate